Co-Diagnostics (CODX) Reports FY Loss of $1.20

Co-Diagnostics (NASDAQ: CODX) reported FY EPS of ($1.20). Revenue for the period came in at $6.8 million.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.

You May Also Be Interested In

• AI and earnings keep driving markets as focus shifts to Trump-Xi summit
• UBS Reiterates Neutral Rating on Pilgrim's Pride (PPC) on 'Challenging' Near-Term Fundamentals
• UBS Reiterates Buy Rating on Option Care Health (OPCH) Following Check-in Call Ahead of Quiet Period